XBP1 and breast cancer: On the other hand, the functional consequences of LOXL2-mediated PERK activation for tumour progression remain to be investigated as well as potential additional mechanisms of LOXL2-mediated IRE1-XBP1 activation as recently reported for oestrogen induced XBP1 in some breast cancer types65.